Adagio Medical appoints Daniel George as Interim CFO effective April 17, 2025

Adagio Medical Holdings, Inc.

Daniel George appointed Interim CFO, principal financial and accounting officer.
Compensation set at $400 per hour; employment is at-will.
George previously served as CFO of Lucira Health and part-time CFO of Anebulo Pharmaceuticals.
No family relationships or material transactions with the company.
Offer letter to be filed with Q1 2025 Form 10-Q.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Daniel George

Interim Chief Financial Officer

ADGM · Adagio Medical Holdings, Inc.

Effective: 2025-04-17
Filed: April 23, 2025, 7:59 PM ET

On April 17, 2025, Adagio Medical Holdings, Inc. (the “Company”) appointed Daniel George as the Company’s Interim Chief Financial Officer and designated Mr. George as its principal financial officer and principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel George was appointed as Interim Chief Financial Officer at Adagio Medical Holdings, Inc..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On April 17, 2025, Adagio Medical Holdings, Inc. (the “Company”) appointed Daniel George as the Company’s Interim Chief Financial Officer and designated Mr. George as its principal financial officer and principal accounting officer.

View on SEC.gov

Adagio Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-005261

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.